aluates Reports

$ 0.0

Automative

Global α4β7 Integrin Antagonists Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-14Y18484

BUY CHAPTERS

Global α4β7 Integrin Antagonists Market Research Report 2024

Code: QYRE-Auto-14Y18484

Report

October 2024

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda

Biogen

Sandoz Inc

Novartis

α4β7 Integrin Antagonists Market Size

The global α4β7 Integrin Antagonists market was valued at US$ 8480 million in 2023 and is anticipated to reach US$ 15910 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.

α4β7 Integrin Antagonists Market

α4β7 integrin antagonists are a class of therapeutic agents that specifically target the α4β7 integrin, a receptor expressed on lymphocytes that plays a crucial role in the homing of these immune cells to the gut. By inhibiting this integrin, these drugs prevent lymphocytes from migrating to inflamed intestinal tissues, making them particularly effective in treating inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.

North American market for α4β7 Integrin Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for α4β7 Integrin Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of α4β7 Integrin Antagonists include Takeda, Biogen, Sandoz, Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for α4β7 Integrin Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding α4β7 Integrin Antagonists.

The α4β7 Integrin Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global α4β7 Integrin Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the α4β7 Integrin Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of α4β7 Integrin Antagonists Market Report

Report Metric	Details
Report Name	α4β7 Integrin Antagonists Market
Accounted market size in 2023	US$ 8480 million
Forecasted market size in 2030	US$ 15910 million
CAGR	9.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Natalizumub Vedolizumab
Segment by Application	Inflammatory Bowel Disease (IBD) Multiple Sclerosis (MS) Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda, Biogen, Sandoz, Novartis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of α4β7 Integrin Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of α4β7 Integrin Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is α4β7 Integrin Antagonists Market growing?

Ans: The α4β7 Integrin Antagonists Market witnessing a CAGR of 9.4% during the forecast period 2024-2030.

What is the α4β7 Integrin Antagonists Market size in 2030?

Ans: The α4β7 Integrin Antagonists Market size in 2030 will be US$ 15910 million.

Who are the main players in the α4β7 Integrin Antagonists Market report?

Ans: The main players in the α4β7 Integrin Antagonists Market are Takeda, Biogen, Sandoz, Novartis

What are the Application segmentation covered in the α4β7 Integrin Antagonists Market report?

Ans: The Applications covered in the α4β7 Integrin Antagonists Market report are Inflammatory Bowel Disease (IBD), Multiple Sclerosis (MS), Other

What are the Type segmentation covered in the α4β7 Integrin Antagonists Market report?

Ans: The Types covered in the α4β7 Integrin Antagonists Market report are Natalizumub, Vedolizumab

Recommended Reports

Digestive Disease Drugs

Integrin and Inhibitors

Immunology and Biosimilars

1 α4β7 Integrin Antagonists Market Overview

1.1 Product Definition

1.2 α4β7 Integrin Antagonists by Type

1.2.1 Global α4β7 Integrin Antagonists Market Value Comparison by Type (2024-2030)

1.2.2 Natalizumub

1.2.3 Vedolizumab

1.3 α4β7 Integrin Antagonists by Application

1.3.1 Global α4β7 Integrin Antagonists Market Value by Application (2024-2030)

1.3.2 Inflammatory Bowel Disease (IBD)

1.3.3 Multiple Sclerosis (MS)

1.3.4 Other

1.4 Global α4β7 Integrin Antagonists Market Size Estimates and Forecasts

1.4.1 Global α4β7 Integrin Antagonists Revenue 2019-2030

1.4.2 Global α4β7 Integrin Antagonists Sales 2019-2030

1.4.3 Global α4β7 Integrin Antagonists Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 α4β7 Integrin Antagonists Market Competition by Manufacturers

2.1 Global α4β7 Integrin Antagonists Sales Market Share by Manufacturers (2019-2024)

2.2 Global α4β7 Integrin Antagonists Revenue Market Share by Manufacturers (2019-2024)

2.3 Global α4β7 Integrin Antagonists Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of α4β7 Integrin Antagonists, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of α4β7 Integrin Antagonists, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of α4β7 Integrin Antagonists, Product Type & Application

2.7 Global Key Manufacturers of α4β7 Integrin Antagonists, Date of Enter into This Industry

2.8 Global α4β7 Integrin Antagonists Market Competitive Situation and Trends

2.8.1 Global α4β7 Integrin Antagonists Market Concentration Rate

2.8.2 The Global 5 and 10 Largest α4β7 Integrin Antagonists Players Market Share by Revenue

2.8.3 Global α4β7 Integrin Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global α4β7 Integrin Antagonists Market Scenario by Region

3.1 Global α4β7 Integrin Antagonists Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global α4β7 Integrin Antagonists Sales by Region: 2019-2030

3.2.1 Global α4β7 Integrin Antagonists Sales by Region: 2019-2024

3.2.2 Global α4β7 Integrin Antagonists Sales by Region: 2025-2030

3.3 Global α4β7 Integrin Antagonists Revenue by Region: 2019-2030

3.3.1 Global α4β7 Integrin Antagonists Revenue by Region: 2019-2024

3.3.2 Global α4β7 Integrin Antagonists Revenue by Region: 2025-2030

3.4 North America α4β7 Integrin Antagonists Market Facts & Figures by Country

3.4.1 North America α4β7 Integrin Antagonists Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America α4β7 Integrin Antagonists Sales by Country (2019-2030)

3.4.3 North America α4β7 Integrin Antagonists Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe α4β7 Integrin Antagonists Market Facts & Figures by Country

3.5.1 Europe α4β7 Integrin Antagonists Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe α4β7 Integrin Antagonists Sales by Country (2019-2030)

3.5.3 Europe α4β7 Integrin Antagonists Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific α4β7 Integrin Antagonists Market Facts & Figures by Region

3.6.1 Asia Pacific α4β7 Integrin Antagonists Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific α4β7 Integrin Antagonists Sales by Region (2019-2030)

3.6.3 Asia Pacific α4β7 Integrin Antagonists Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America α4β7 Integrin Antagonists Market Facts & Figures by Country

3.7.1 Latin America α4β7 Integrin Antagonists Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America α4β7 Integrin Antagonists Sales by Country (2019-2030)

3.7.3 Latin America α4β7 Integrin Antagonists Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa α4β7 Integrin Antagonists Market Facts & Figures by Country

3.8.1 Middle East and Africa α4β7 Integrin Antagonists Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa α4β7 Integrin Antagonists Sales by Country (2019-2030)

3.8.3 Middle East and Africa α4β7 Integrin Antagonists Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global α4β7 Integrin Antagonists Sales by Type (2019-2030)

4.1.1 Global α4β7 Integrin Antagonists Sales by Type (2019-2024)

4.1.2 Global α4β7 Integrin Antagonists Sales by Type (2025-2030)

4.1.3 Global α4β7 Integrin Antagonists Sales Market Share by Type (2019-2030)

4.2 Global α4β7 Integrin Antagonists Revenue by Type (2019-2030)

4.2.1 Global α4β7 Integrin Antagonists Revenue by Type (2019-2024)

4.2.2 Global α4β7 Integrin Antagonists Revenue by Type (2025-2030)

4.2.3 Global α4β7 Integrin Antagonists Revenue Market Share by Type (2019-2030)

4.3 Global α4β7 Integrin Antagonists Price by Type (2019-2030)

5 Segment by Application

5.1 Global α4β7 Integrin Antagonists Sales by Application (2019-2030)

5.1.1 Global α4β7 Integrin Antagonists Sales by Application (2019-2024)

5.1.2 Global α4β7 Integrin Antagonists Sales by Application (2025-2030)

5.1.3 Global α4β7 Integrin Antagonists Sales Market Share by Application (2019-2030)

5.2 Global α4β7 Integrin Antagonists Revenue by Application (2019-2030)

5.2.1 Global α4β7 Integrin Antagonists Revenue by Application (2019-2024)

5.2.2 Global α4β7 Integrin Antagonists Revenue by Application (2025-2030)

5.2.3 Global α4β7 Integrin Antagonists Revenue Market Share by Application (2019-2030)

5.3 Global α4β7 Integrin Antagonists Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Takeda

6.1.1 Takeda Company Information

6.1.2 Takeda Description and Business Overview

6.1.3 Takeda α4β7 Integrin Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Takeda α4β7 Integrin Antagonists Product Portfolio

6.1.5 Takeda Recent Developments/Updates

6.2 Biogen

6.2.1 Biogen Company Information

6.2.2 Biogen Description and Business Overview

6.2.3 Biogen α4β7 Integrin Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Biogen α4β7 Integrin Antagonists Product Portfolio

6.2.5 Biogen Recent Developments/Updates

6.3 Sandoz

6.3.1 Sandoz Company Information

6.3.2 Sandoz Description and Business Overview

6.3.3 Sandoz α4β7 Integrin Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sandoz α4β7 Integrin Antagonists Product Portfolio

6.3.5 Sandoz Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Company Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis α4β7 Integrin Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis α4β7 Integrin Antagonists Product Portfolio

6.4.5 Novartis Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 α4β7 Integrin Antagonists Industry Chain Analysis

7.2 α4β7 Integrin Antagonists Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 α4β7 Integrin Antagonists Production Mode & Process

7.4 α4β7 Integrin Antagonists Sales and Marketing

7.4.1 α4β7 Integrin Antagonists Sales Channels

7.4.2 α4β7 Integrin Antagonists Distributors

7.5 α4β7 Integrin Antagonists Customers

8 α4β7 Integrin Antagonists Market Dynamics

8.1 α4β7 Integrin Antagonists Industry Trends

8.2 α4β7 Integrin Antagonists Market Drivers

8.3 α4β7 Integrin Antagonists Market Challenges

8.4 α4β7 Integrin Antagonists Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda

Biogen

Sandoz Inc

Novartis

List of Tables

Table 1. Global α4β7 Integrin Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global α4β7 Integrin Antagonists Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global α4β7 Integrin Antagonists Market Competitive Situation by Manufacturers in 2023

Table 4. Global α4β7 Integrin Antagonists Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global α4β7 Integrin Antagonists Sales Market Share by Manufacturers (2019-2024)

Table 6. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global α4β7 Integrin Antagonists Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market α4β7 Integrin Antagonists Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of α4β7 Integrin Antagonists, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of α4β7 Integrin Antagonists, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of α4β7 Integrin Antagonists, Product Type & Application

Table 12. Global Key Manufacturers of α4β7 Integrin Antagonists, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global α4β7 Integrin Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in α4β7 Integrin Antagonists as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global α4β7 Integrin Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global α4β7 Integrin Antagonists Sales by Region (2019-2024) & (K Units)

Table 18. Global α4β7 Integrin Antagonists Sales Market Share by Region (2019-2024)

Table 19. Global α4β7 Integrin Antagonists Sales by Region (2025-2030) & (K Units)

Table 20. Global α4β7 Integrin Antagonists Sales Market Share by Region (2025-2030)

Table 21. Global α4β7 Integrin Antagonists Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global α4β7 Integrin Antagonists Revenue Market Share by Region (2019-2024)

Table 23. Global α4β7 Integrin Antagonists Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global α4β7 Integrin Antagonists Revenue Market Share by Region (2025-2030)

Table 25. North America α4β7 Integrin Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America α4β7 Integrin Antagonists Sales by Country (2019-2024) & (K Units)

Table 27. North America α4β7 Integrin Antagonists Sales by Country (2025-2030) & (K Units)

Table 28. North America α4β7 Integrin Antagonists Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America α4β7 Integrin Antagonists Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe α4β7 Integrin Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe α4β7 Integrin Antagonists Sales by Country (2019-2024) & (K Units)

Table 32. Europe α4β7 Integrin Antagonists Sales by Country (2025-2030) & (K Units)

Table 33. Europe α4β7 Integrin Antagonists Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe α4β7 Integrin Antagonists Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific α4β7 Integrin Antagonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific α4β7 Integrin Antagonists Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific α4β7 Integrin Antagonists Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific α4β7 Integrin Antagonists Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific α4β7 Integrin Antagonists Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America α4β7 Integrin Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America α4β7 Integrin Antagonists Sales by Country (2019-2024) & (K Units)

Table 42. Latin America α4β7 Integrin Antagonists Sales by Country (2025-2030) & (K Units)

Table 43. Latin America α4β7 Integrin Antagonists Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America α4β7 Integrin Antagonists Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa α4β7 Integrin Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa α4β7 Integrin Antagonists Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa α4β7 Integrin Antagonists Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa α4β7 Integrin Antagonists Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa α4β7 Integrin Antagonists Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global α4β7 Integrin Antagonists Sales (K Units) by Type (2019-2024)

Table 51. Global α4β7 Integrin Antagonists Sales (K Units) by Type (2025-2030)

Table 52. Global α4β7 Integrin Antagonists Sales Market Share by Type (2019-2024)

Table 53. Global α4β7 Integrin Antagonists Sales Market Share by Type (2025-2030)

Table 54. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Type (2019-2024)

Table 55. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Type (2025-2030)

Table 56. Global α4β7 Integrin Antagonists Revenue Market Share by Type (2019-2024)

Table 57. Global α4β7 Integrin Antagonists Revenue Market Share by Type (2025-2030)

Table 58. Global α4β7 Integrin Antagonists Price (US$/Unit) by Type (2019-2024)

Table 59. Global α4β7 Integrin Antagonists Price (US$/Unit) by Type (2025-2030)

Table 60. Global α4β7 Integrin Antagonists Sales (K Units) by Application (2019-2024)

Table 61. Global α4β7 Integrin Antagonists Sales (K Units) by Application (2025-2030)

Table 62. Global α4β7 Integrin Antagonists Sales Market Share by Application (2019-2024)

Table 63. Global α4β7 Integrin Antagonists Sales Market Share by Application (2025-2030)

Table 64. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Application (2019-2024)

Table 65. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Application (2025-2030)

Table 66. Global α4β7 Integrin Antagonists Revenue Market Share by Application (2019-2024)

Table 67. Global α4β7 Integrin Antagonists Revenue Market Share by Application (2025-2030)

Table 68. Global α4β7 Integrin Antagonists Price (US$/Unit) by Application (2019-2024)

Table 69. Global α4β7 Integrin Antagonists Price (US$/Unit) by Application (2025-2030)

Table 70. Takeda Company Information

Table 71. Takeda Description and Business Overview

Table 72. Takeda α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Takeda α4β7 Integrin Antagonists Product

Table 74. Takeda Recent Developments/Updates

Table 75. Biogen Company Information

Table 76. Biogen Description and Business Overview

Table 77. Biogen α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Biogen α4β7 Integrin Antagonists Product

Table 79. Biogen Recent Developments/Updates

Table 80. Sandoz Company Information

Table 81. Sandoz Description and Business Overview

Table 82. Sandoz α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sandoz α4β7 Integrin Antagonists Product

Table 84. Sandoz Recent Developments/Updates

Table 85. Novartis Company Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Novartis α4β7 Integrin Antagonists Product

Table 89. Novartis Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. α4β7 Integrin Antagonists Distributors List

Table 93. α4β7 Integrin Antagonists Customers List

Table 94. α4β7 Integrin Antagonists Market Trends

Table 95. α4β7 Integrin Antagonists Market Drivers

Table 96. α4β7 Integrin Antagonists Market Challenges

Table 97. α4β7 Integrin Antagonists Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of α4β7 Integrin Antagonists

Figure 2. Global α4β7 Integrin Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global α4β7 Integrin Antagonists Market Share by Type: 2023 & 2030

Figure 4. Natalizumub Product Picture

Figure 5. Vedolizumab Product Picture

Figure 6. Global α4β7 Integrin Antagonists Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global α4β7 Integrin Antagonists Market Share by Application: 2023 & 2030

Figure 8. Inflammatory Bowel Disease (IBD)

Figure 9. Multiple Sclerosis (MS)

Figure 10. Other

Figure 11. Global α4β7 Integrin Antagonists Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global α4β7 Integrin Antagonists Market Size (2019-2030) & (US$ Million)

Figure 13. Global α4β7 Integrin Antagonists Sales (2019-2030) & (K Units)

Figure 14. Global α4β7 Integrin Antagonists Average Price (US$/Unit) & (2019-2030)

Figure 15. α4β7 Integrin Antagonists Report Years Considered

Figure 16. α4β7 Integrin Antagonists Sales Share by Manufacturers in 2023

Figure 17. Global α4β7 Integrin Antagonists Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest α4β7 Integrin Antagonists Players: Market Share by Revenue in α4β7 Integrin Antagonists in 2023

Figure 19. α4β7 Integrin Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global α4β7 Integrin Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America α4β7 Integrin Antagonists Sales Market Share by Country (2019-2030)

Figure 22. North America α4β7 Integrin Antagonists Revenue Market Share by Country (2019-2030)

Figure 23. United States α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe α4β7 Integrin Antagonists Sales Market Share by Country (2019-2030)

Figure 26. Europe α4β7 Integrin Antagonists Revenue Market Share by Country (2019-2030)

Figure 27. Germany α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific α4β7 Integrin Antagonists Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific α4β7 Integrin Antagonists Revenue Market Share by Region (2019-2030)

Figure 34. China α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America α4β7 Integrin Antagonists Sales Market Share by Country (2019-2030)

Figure 42. Mexico α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa α4β7 Integrin Antagonists Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa α4β7 Integrin Antagonists Revenue Market Share by Country (2019-2030)

Figure 48. Turkey α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE α4β7 Integrin Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of α4β7 Integrin Antagonists by Type (2019-2030)

Figure 52. Global Revenue Market Share of α4β7 Integrin Antagonists by Type (2019-2030)

Figure 53. Global α4β7 Integrin Antagonists Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of α4β7 Integrin Antagonists by Application (2019-2030)

Figure 55. Global Revenue Market Share of α4β7 Integrin Antagonists by Application (2019-2030)

Figure 56. Global α4β7 Integrin Antagonists Price (US$/Unit) by Application (2019-2030)

Figure 57. α4β7 Integrin Antagonists Value Chain

Figure 58. α4β7 Integrin Antagonists Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Integrin Inhibitors Market Research Report 2024

Global αIIbβ3 Antagonists Market Research Report 2024

Global Small Molecule αIIbβ3 Antagonists Market Research Report 2024

Global IL 23 Receptor Antagonist Market Research Report 2024

Global Small Molecules Drugs for Inflammatory Bowel Diseases IBDs Market Research Report 2024

Global Integrin Alpha 4 Market Research Report 2025

Global Biologics Targeting CCR4 Market Research Report 2024

Global Tumor Necrosis Factor TNF Antagonists Market Research Report 2024

Global CXCR4 Antagonists Market Insights Forecast to 2030

Global GLP 1 Receptor Antagonist Market Research Report 2024

Global Purinergic Receptor Antagonists Market Research Report 2024

Global Androgen Receptor AR Antagonist Market Research Report 2024

Global Tumor Necrosis Factor Alpha Inhibitors Market Research Report 2024

Global Integrin Beta3 Antibody Market Research Report 2024

Endothelin Antagonists Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Intestinal Inflammation Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Interleukin 17 Inhibitors Market Research Report 2024

Global FLT3 Antagonists Market Research Report 2024

Global Human Integrin Beta3 Antibody Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions